Wegovy, Ozempic Maker Novo's Ceo Reacts To Pfizer Deal Win

Novo Nordisk A/S Chief Executive Officer Mike Doustdar may have lost out to Pfizer Inc. in a $10 billion takeover battle for obesity drug developer Metsera Inc. But don’t expect him to give up on dealmaking any time soon as the Danish company seeks t ...Read more